Literature DB >> 27826657

ST-segment category at acute presentation is associated with the time course of coronary artery disease progression in patients with acute coronary syndromes.

Tatsuya Nakachi1, Masami Kosuge2, Naoki Iinuma3, Hidekuni Kirigaya3, Shingo Kato3, Kazuki Fukui3, Kazuo Kimura2.   

Abstract

BACKGROUND: Several studies have shown higher early mortality for ST-segment elevation acute coronary syndrome (STEACS), but late mortality remains consistently higher for non-ST-segment elevation acute coronary syndrome (NSTEACS). We hypothesized that ST-segment category at acute presentation is associated with the time course of coronary artery disease progression (CP) of nonculprit lesions in patients with acute coronary syndrome (ACS).
METHODS: A total of 226 patients (182 men, age 65 ± 10 years) with STEACS (n = 95) or NSTEACS (n = 131) who underwent percutaneous coronary intervention (PCI) during initial hospitalization were studied. All patients underwent serial coronary angiograms (CAGs) performed immediately before PCI and at 7 ± 3 months and 60 ± 10 months after presentation. CP was defined as an increase in stenosis severity >15% of a nonculprit lesion between 2 serial CAGs.
RESULTS: The rate of CP between the first and second CAGs did not differ by ST-segment category at acute presentation. Compared to STEACS, NSTEACS had a higher rate of CP between the second and final CAGs (27.4 vs. 42.7%, P = 0.018). Multivariate analysis showed that the independent predictors of CP between the second and final CAGs were NSTEACS (odds ratio 2.709, P = 0.003), estimated glomerular filtration rate <60 ml/min/1.73 m2 (odds ratio 2.447, P = 0.015), and diabetes mellitus (odds ratio 2.135, P = 0.021).
CONCLUSIONS: Irrespective of conventional risk factors and angiographic findings, ST-segment category at initial presentation is associated with the persistency of widespread coronary disease activity following presentation in ACS patients undergoing PCI. This may partly explain the time-dependent differences in outcomes of patients with STEACS and NSTEACS.

Entities:  

Keywords:  Acute coronary syndromes; Coronary angiography; Follow-up study

Mesh:

Substances:

Year:  2016        PMID: 27826657     DOI: 10.1007/s00380-016-0917-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression.

Authors:  E G Zouridakis; R Schwartzman; X Garcia-Moll; I D Cox; S Fredericks; D W Holt; J C Kaski
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

2.  Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up.

Authors:  Sami M A Alnasser; Wei Huang; Joel M Gore; Ph Gabriel Steg; Kim A Eagle; Frederick A Anderson; Keith A A Fox; Enrique Gurfinkel; David Brieger; Werner Klein; Frans van de Werf; Álvaro Avezum; Gilles Montalescot; Dietrich C Gulba; Andrzej Budaj; Jose Lopez-Sendon; Christopher B Granger; Brian M Kennelly; Robert J Goldberg; Emily Fleming; Shaun G Goodman
Journal:  Am J Med       Date:  2014-12-29       Impact factor: 4.965

3.  Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).

Authors:  Keith A A Fox; Kathryn F Carruthers; Donald R Dunbar; Catriona Graham; Jonathan R Manning; Herbert De Raedt; Ian Buysschaert; Diether Lambrechts; Frans Van de Werf
Journal:  Eur Heart J       Date:  2010-08-30       Impact factor: 29.983

Review 4.  C-reactive protein increase in unstable coronary disease cause or effect?

Authors:  Stefano De Servi; Matteo Mariani; Giuseppe Mariani; Antonino Mazzone
Journal:  J Am Coll Cardiol       Date:  2005-09-28       Impact factor: 24.094

5.  Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.

Authors:  Tomotaka Dohi; Takatoshi Kasai; Katsumi Miyauchi; Kiyoshi Takasu; Kan Kajimoto; Naozumi Kubota; Atsushi Amano; Hiroyuki Daida
Journal:  J Cardiol       Date:  2012-10-12       Impact factor: 3.159

6.  Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.

Authors:  Mark Y Chan; Jie L Sun; L Kristin Newby; Linda K Shaw; Min Lin; Eric D Peterson; Robert M Califf; David F Kong; Matthew T Roe
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

7.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

8.  Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease.

Authors:  M R Chester; L Chen; D Tousoulis; J Poloniecki; J C Kaski
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

9.  Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.

Authors:  Liang Tang; Zhen-Fei Fang; Sheng-Hua Zhou; Shi Tai; Salah Ahmed; Feng Huang; Xiang-Qian Shen; Yan-Shu Zhao; Xin-Qun Hu
Journal:  Heart Vessels       Date:  2015-10-23       Impact factor: 2.037

10.  Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.

Authors:  Hideki Miyachi; Atsushi Takagi; Katsumi Miyauchi; Masao Yamasaki; Hiroyuki Tanaka; Masatomo Yoshikawa; Mike Saji; Makoto Suzuki; Takeshi Yamamoto; Wataru Shimizu; Ken Nagao; Morimasa Takayama
Journal:  Heart Vessels       Date:  2016-01-12       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.